These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17057183)

  • 1. The international intravitreal bevacizumab safety survey.
    Ziemssen F; Grisanti S; Bartz-Schmidt KU
    Br J Ophthalmol; 2006 Nov; 90(11):1440-1. PubMed ID: 17057183
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU
    Acta Ophthalmol Scand; 2006 Dec; 84(6):833-4. PubMed ID: 17083554
    [No Abstract]   [Full Text] [Related]  

  • 3. Case of anterior uveitis after intravitreal injection of bevacizumab.
    Pieramici DJ; Avery RL; Castellarin AA; Nasir MA; Rabena M
    Retina; 2006 Sep; 26(7):841-2. PubMed ID: 16963867
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab.
    Yoon YH; Kim JG; Chung H; Lee SY
    Acta Ophthalmol; 2009 Sep; 87(6):685-7. PubMed ID: 18705680
    [No Abstract]   [Full Text] [Related]  

  • 5. Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story.
    Quiroz-Mercado H; Ustariz-González O; Martinez-Castellanos MA; Covarrubias P; Dominguez F; Sanchez-Huerta V
    Semin Ophthalmol; 2007; 22(2):109-25. PubMed ID: 17564934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA;
    Retina; 2008; 28(10):1387-94. PubMed ID: 18827735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.
    Fung AE; Rosenfeld PJ; Reichel E
    Br J Ophthalmol; 2006 Nov; 90(11):1344-9. PubMed ID: 16854824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in the treatment of wet age-related macular degeneration.
    Moreno SF; Paloma JB
    Am J Ophthalmol; 2008 May; 145(5):937; author reply 938. PubMed ID: 18435977
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Rich RM; Rosenfeld PJ; Puliafito CA; Dubovy SR; Davis JL; Flynn HW; Gonzalez S; Feuer WJ; Lin RC; Lalwani GA; Nguyen JK; Kumar G
    Retina; 2006; 26(5):495-511. PubMed ID: 16770255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab.
    Lucas RS; McKee HD; Lee LR
    Ophthalmology; 2007 Feb; 114(2):400; author reply 400-1. PubMed ID: 17270701
    [No Abstract]   [Full Text] [Related]  

  • 11. Bevacizumab local complications.
    Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V
    Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Bom Aggio F; Eid Farah M; Melo GB
    Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.
    Meyer CH; Mennel S; Schmidt JC; Kroll P
    Br J Ophthalmol; 2006 Sep; 90(9):1207-8. PubMed ID: 16929069
    [No Abstract]   [Full Text] [Related]  

  • 14. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
    Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
    Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
    Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
    Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.
    Bashshur ZF; Bazarbachi A; Schakal A; Haddad ZA; El Haibi CP; Noureddin BN
    Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
    Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
    Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravitreal bevacizumab (Avastin) in neovascular age-related macular degeneration using a treatment regimen based on optical coherence tomography: 6- and 12-month results.
    Leydolt C; Michels S; Prager F; Garhoefer G; Georgopoulos M; Polak K; Schmidt-Erfurth U
    Acta Ophthalmol; 2010 Aug; 88(5):594-600. PubMed ID: 19485959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study.
    Costa RA; Jorge R; Calucci D; Cardillo JA; Melo LA; Scott IU
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4569-78. PubMed ID: 17003454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual hallucinations after intravitreal injection of bevacizumab in vascular age-related macular degeneration.
    Meyer CH; Mennel S; Hörle S; Schmidt JC
    Am J Ophthalmol; 2007 Jan; 143(1):169-70. PubMed ID: 17188061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.